Prospective Single-Arm Clinical Trial of GO Regimen for HLH.
NCT07339345
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
RECRUITING
Status
28
Enrollment
OTHER
Sponsor class
Conditions
Lymphohistiocytosis, Hemophagocytic
Interventions
DRUG:
Golidocitinib
Sponsor
Beijing Friendship Hospital